Viewing nowCombinationNexpod 5/160 milligrams
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201309133 · Approved 2013.08.30 · Insurance code 649404580
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in the treatment of essential hypertension when the patient's blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its administration is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or similar class drugs should not take it. It is safest for women who are pregnant or breastfeeding to avoid using this medication. Patients with very poor kidney function or serious liver problems should not take this medication. Diabetic patients or those with moderate to severe kidney impairment should avoid taking this medication with certain other medications containing specific ingredients. Patients with a history of angioedema or those who have experienced angioedema due to related medications should also avoid this medication. This medication is contraindicated in patients with severe aortic stenosis or in shock. If there is sodium or fluid depletion, the condition should be well controlled before taking this medication, and blood pressure and condition should be carefully monitored during use. Patients with high potassium levels should frequently check their potassium levels when taking this medication along with potassium supplements or potassium-sparing diuretics. Patients with renal artery stenosis need to be cautious due to the risk of worsening kidney function. For patients who have recently undergone kidney transplantation, the safety of this medication has not been established, so it is best not to use it. If symptoms of angioedema occur, the medication should be stopped immediately and should not be re-dosed. Patients with heart failure or post-myocardial infarction should have their kidney function periodically evaluated during treatment with this medication, paying particular attention to symptoms. In acute myocardial infarction patients, symptoms of angina or myocardial infarction may worsen after taking this medication, necessitating caution. Patients with certain heart valve diseases or obstructive cardiomyopathy should exercise special caution when taking this medication. This medication is not recommended to be taken with other medications that act on the renin-angiotensin-aldosterone system. Patients with mild to moderate liver impairment should adjust the dosage of this medication accordingly. Dizziness or fatigue may appear during the course of this medication, so care should be taken when driving or operating machinery. In cases of overdose, symptoms such as hypotension or increased heart rate may occur, so immediate medical attention is required. This medication is not recommended for children as its safety and effectiveness have not been adequately established. Elderly patients can take the same dosage as adults but should be carefully monitored for their condition. During the course of this medication, blood pressure, kidney function, and potassium levels should be regularly checked to ensure there are no abnormalities. There may be interactions with other medications, so if you are taking other medicines, be sure to inform your doctor or pharmacist.
nasopharyngitis, influenza, hypersensitivity, visual disturbance, anxiety, headache, dizziness, drowsiness, postural dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, lumbago, arthritis, muscle spasms, lethargy, frequent urination, polyuria, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, reduced hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney injury, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, throat pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy and safety of the medication.
Yellow oval film-coated tablet
Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.